Komfo Anokye Eğitim Hastanesinde sinonazal kanserlerin klinik ve histopatolojik özellikleri

Year 2016, Volume: 6 Issue: 2, 87 - 90, 31.08.2016

Joseph Opoku-buabeng Seth Acquah

Abstract

Objective: To determine the incidence, clinical and histopathological presentations of the paranasal sinus tumors in Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Methods: All cases of sinonasal cancers diagnosed between January 2007 and December 2012 were retrospectively reviewed.
Results: Of the 68 patients (38 males, 30 females) whose charts were reviewed, the median age was 49 (range: 14 to 84) years. The common clinical presentations were epistaxis (23%), nasal mass (20%), headache (12%), nasal blockage (12%), nasal discharge (11%), proptosis (9%), cheek swelling (8%), and epiphora (5%). The most common histopathological subtypes were squamous cell carcinoma (39.6%) and adenocarcinoma (25%).
Conclusion: Sinonasal tumors are frequent in male adults and present with epistaxis, nasal mass, blocked nose and nasal discharge, while squamous cell carcinoma remains the common histopathological type.

Keywords

Paranazal sinüs, tümör, klinik, histopatolojik, Paranasal sinus, tumor, clinical, histopathological

References

• 1. Kuijpens JHLP, Louwman MWJ, Peters R, Janssens GORJ, Burdorf AL, Coebergh JWW. Trends in sinonasal cancer in The Netherlands: more squamous cell cancer, less adenocarcinoma. A population-based study 1973-2009. Eur J Cancer 2012;48: 2369–74.
• 2. Myers LL, Nussenbaum B, Bradford CR, Teknos TN, Esclamado RM, Wolf GT. Paranasal sinus malignances: an 18- year single institution experience. Laryngoscope 2002;112:1964–9.
• 3. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92: 3012–29.
• 4. Weber AL. Tumors of the paranasal sinuses. Otolaryngol Clin North Am 1988;21:439–54.
• 5. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231–6.
• 6. Arnold A, Ziglinas P, Ochs K, et al. Therapy options and longterm results of sinonasal malignancies. Oral Oncol 2012;48: 1031–7.
• 7. Betlejewski S, Bilewicz R, Stankiewicz C, et al. Malignant tumours of the nose and paranasal sinuses in the years 1992–2001. [Article in Polish] Otolaryngol Pol 2006;60:729–36.
• 8. Fasunla AJ, Lasisi AO. Sinonasal malignancies: a 10-year review in a tertiary health institution. J Natl Med Assoc 2007;99:1407–10.
• 9. Brobby GW. Cancer of the maxillary sinus and its management in Kumasi, Ghana. Journal of the University of Science and Technology (Kumasi) 1988;8:1–6.
• 10. Myers LL, Oxford LE. Differential diagnosis and treatment options in paranasal sinus cancers. Surg Oncol Clin North Am 2004;13:167–86.
• 11. Koivunen P, Mäkitie AA, Bäck L, et al. A national series of 244 sinonasal cancers in Finland in 1990–2004. Eur Arch Otorhinolaryngol 2012;269:615–21.
• 12. Waldron JN, O’Sullivan B, Gullane P, et al. Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 2000;57:167–73.
• 13. Madison Michael L 2nd, Sorenson JM, Samant S, Robertson JH. The treatment of advanced sinonasal malignancies with preoperative intra-arterial cisplatin and concurrent radiation. J Neurooncol 2005;72:67–75.
• 14. Zyłka S, Bień S, Kamiński B, Postuła S, Ziołkowska M. Epidemiology and clinical characteristics of sinonasal malignancies. [Article in Polish] Otolaryngol Pol 2008;62:436–41.
• 15. Carrau RL, Myers EM, Johnson JT. Paranasal sinus carcinoma – diagnosis, treatment and prognosis. Oncology (Williston Park) 1992;6:43–50; discussion 55–6.